Home / Community / News / News

News

02/24/2017 - 9:59am

FDA released an online course to accompany their draft guidance on how to best communicate with the Agency in preparing and filing an IND.

02/24/2017 - 9:50am

Gene editing is a potential avenue for therapy development in DM. With the safety, efficacy and delivery challenges, how do we get there?

02/02/2017 - 2:54pm

When Dr. Thurman Wheeler was a resident in neurology, he remembers a senior physician telling him that myotonic dystrophy would probably be one of the most difficult diseases to treat because it involves so many body systems.

02/02/2017 - 2:24pm

Sleep studies are indicated for DM1 patients with disrupted sleep or daytime sleepiness in order to direct selection of the optimal treatment regimen.

02/02/2017 - 2:17pm

A new clinical trial planning grant initiative from the National Institute of Nursing Research (NINR) provides opportunities to develop an evidentiary basis for the consensus-driven clinical care recommendations currently under development at MDF for DM1.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.